statistiche ricercatore

PEGHIN, MADDALENA

Distribuzione geografica

Continente	#
NA - Nord America	4.099
EU - Europa	3.580
AS - Asia	2.606
SA - Sud America	316
Continente sconosciuto - Info sul continente non disponibili	121
AF - Africa	46
OC - Oceania	3
Totale	10.771

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	3.978
IT - Italia	2.379
SG - Singapore	1.094
CN - Cina	604
HK - Hong Kong	375
BR - Brasile	258
IE - Irlanda	245
GB - Regno Unito	204
VN - Vietnam	200
SE - Svezia	149
FR - Francia	127
RU - Federazione Russa	118
FI - Finlandia	108
BD - Bangladesh	99
IN - India	83
DE - Germania	80
CA - Canada	57
MX - Messico	41
JP - Giappone	40
NL - Olanda	36
ES - Italia	26
AT - Austria	25
UA - Ucraina	23
IQ - Iraq	22
PL - Polonia	19
AR - Argentina	18
TR - Turchia	17
CZ - Repubblica Ceca	15
ZA - Sudafrica	11
EC - Ecuador	10
NG - Nigeria	10
CO - Colombia	9
VE - Venezuela	9
EG - Egitto	8
MY - Malesia	8
AE - Emirati Arabi Uniti	7
SY - Repubblica araba siriana	7
PK - Pakistan	6
SA - Arabia Saudita	6
UZ - Uzbekistan	6
CH - Svizzera	5
JM - Giamaica	5
JO - Giordania	5
LT - Lituania	5
UY - Uruguay	5
CR - Costa Rica	4
DZ - Algeria	4
EU - Europa	4
ID - Indonesia	4
MA - Marocco	4
NP - Nepal	4
PH - Filippine	4
AU - Australia	3
AZ - Azerbaigian	3
HN - Honduras	3
HU - Ungheria	3
KG - Kirghizistan	3
PY - Paraguay	3
TT - Trinidad e Tobago	3
AL - Albania	2
AM - Armenia	2
BB - Barbados	2
BG - Bulgaria	2
CL - Cile	2
GT - Guatemala	2
KE - Kenya	2
MD - Moldavia	2
PE - Perù	2
TN - Tunisia	2
UG - Uganda	2
AO - Angola	1
BE - Belgio	1
BH - Bahrain	1
BY - Bielorussia	1
DK - Danimarca	1
ET - Etiopia	1
GA - Gabon	1
GR - Grecia	1
KH - Cambogia	1
KR - Corea	1
LB - Libano	1
LU - Lussemburgo	1
MM - Myanmar	1
NI - Nicaragua	1
OM - Oman	1
PA - Panama	1
PR - Porto Rico	1
PT - Portogallo	1
QA - Qatar	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	10.655

Salva come PNG Salva come JPEG

Città	#
Milan	1.686
San Jose	677
Singapore	557
Ashburn	530
Dallas	405
Hong Kong	368
Council Bluffs	276
Dublin	244
Beijing	171
Chicago	154
The Dalles	152
Rome	144
Boardman	116
Nyköping	114
Lauterbourg	106
Chandler	101
London	98
Princeton	96
Helsinki	93
Ho Chi Minh City	84
Los Angeles	81
Santa Clara	77
New York	62
Washington	60
Hanoi	42
Fairfield	38
Tokyo	38
Orem	35
São Paulo	29
Seattle	28
Pune	27
Ogden	24
Chennai	22
Guangzhou	22
Montreal	22
Mexico City	21
Frankfurt am Main	19
Nuremberg	19
Brooklyn	18
Warsaw	18
Houston	17
Amsterdam	16
Atlanta	16
Buffalo	16
San Francisco	16
Shanghai	16
San Diego	15
Brno	14
Denver	14
Manchester	14
Hangzhou	13
Kilburn	13
Memphis	13
Assago	12
Dong Ket	12
Munich	12
Boston	11
Da Nang	11
Poplar	11
Abuja	10
Jacksonville	10
Vienna	10
Brasília	9
Falkenstein	9
Lappeenranta	9
Paris	9
Salt Lake City	9
Stockholm	9
Belo Horizonte	8
Cambridge	8
Düsseldorf	8
Las Vegas	8
Wilmington	8
Woodbridge	8
Changsha	7
Johannesburg	7
Phoenix	7
Portsmouth	7
Rio de Janeiro	7
Varese	7
Aldeatejada	6
Ankara	6
Bologna	6
Cairo	6
Goiânia	6
Hounslow	6
New Bedfont	6
Ninh Bình	6
Tianjin	6
Toronto	6
Acton	5
Amman	5
Bogotá	5
Can Tho	5
Chiswick	5
Dalian	5
Damascus	5
Dhaka	5
Elk Grove Village	5
Genoa	5
Totale	7.420

Salva come PNG Salva come JPEG

Nome	#
Acceptance of Organs from Deceased Donors With Resolved or Active SARS-CoV-2 Infection: A Survey From the Council of Europe	234
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections	210
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant	201
Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality	164
Causes of Death in a Contemporary Cohort of Patients with Invasive Aspergillosis	158
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)	153
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience	138
CARVs, CLAD, and CMV: A Call for Heightened Awareness in Lung Transplant Recipients	135
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study	133
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study	129
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains	125
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study	124
Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review	120
How to manage KPC infections	119
Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study	115
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?	114
A look at clinical trial design for new antimicrobials for the adult population	113
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination	111
Clinical efficacy of beta-lactam/beta-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR)	111
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection After Liver Transplantation: A Multinational Cohort Study	110
One Word to Describe My Experience as a COVID-19 Survivor Six Months after Its Onset: Findings of a Qualitative Study	109
'Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients': authors' response	106
Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa	105
SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients	103
Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance	102
Clinical characteristics and outcome of 125 polymicrobial bloodstream infections in hematological patients: an 11-year epidemiologic survey	101
10years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation	101
Donor-derived carbapenem-resistant gram-negative bacterial infections in solid organ transplant recipients: active surveillance enhances recipient safety	100
Perioperative Antibiotic Stewardship in the Organ Transplant Setting	95
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients	95
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study	95
The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery	93
Risk scores and surgery for infective endocarditis: in search of a good predictive score	92
Neuroinvasive West Nile Infection with an Unusual Clinical Presentation: A Single-Center Case Series	88
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance	88
Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature	88
Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective Study	88
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project	88
Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis	87
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study	86
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality	86
Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge	85
The changing epidemiology of spinal tuberculosis: the influence of international immigration in Catalonia, 1993-2014	85
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study	85
Prevention and Treatment of Respiratory Virus Infection	84
Saprochaete capitata aortitis in an immunocomopetent patient after myocardial revascularization	84
Antibiotic Prophylaxis in Patients Undergoing Lung Transplant: Single-Center Cohort Study	84
Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients	84
Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam	83
Longest incubation period of Mycobacterium chimaera infection after cardiac surgery	83
Gram-negative bacteria as a cause of mediastinitis after cardiac surgery	82
Efficacy of beta-Lactam/beta-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia	82
Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy	82
The management of multidrug-resistant Enterobacteriaceae	82
Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors	81
Cystic dystrophy of the pancreas in patient with only one previous cyst	81
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa	81
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis	80
Effects of Immunocompromise and Comorbidities on Pneumococcal Serotypes Causing Invasive Respiratory Infection in Adults: Implications for Vaccine Strategies	80
Environmental variables associated with an increased risk of invasive aspergillosis	80
Mycobacterium chimaera infection after cardiac surgery: Catastrophic effects of delayed diagnosis	79
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)	79
Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections	79
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis	79
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia	78
Salvage heart transplantation for Mycoplasma hominis prosthetic valve endocarditis: A case report and review of the literature	78
Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam	78
The current treatment landscape: candidiasis	78
Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients	78
Fungal Endogenous Endophthalmitis Secondary to Magnusiomyces capitatus	78
When to switch to an oral treatment and/or to discharge a patient with skin and soft tissue infections	78
Prognostic Role of Malnutrition Diagnosed by Bioelectrical Impedance Vector Analysis in Older Adults Hospitalized with COVID-19 Pneumonia: A Prospective Study	78
Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?	77
Risk Factors for Candidemia After Open Heart Surgery: Results From a Multicenter Case-Control Study	76
What Kind of Interventions Were Perceived as Effective Against Coronavirus-19 in Nursing Homes in Italy? A Descriptive Qualitative Study	76
Community-acquired pneumonia: is less more?	75
Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia	75
The burden of severe cases of Influenza disease: the Friuli Venezia Giulia Region experience	75
Risk factors for infection after carbapenem-resistant Acinetobacter baumannii colonization	75
Multidrug-resistant Gram-negative bacteria-resistant infections: epidemiology, clinical issues and therapeutic options	75
Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients	74
COVID-19 positive donor for solid organ transplantation	74
The safety of treatment options for acute bacterial skin and skin structure infections	74
Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe	74
New antibiotics for ventilator-associated pneumonia	74
Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria	73
The role of dalbavancin in skin and soft tissue infections	73
Treatment of Infections Due to MDR Gram-Negative Bacteria	73
Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection	73
Successful JC virus-targeted T-cell therapy for progressive multifocal leukoencephalopathy in a lung transplant recipient	72
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country	72
Recent concepts in fungal involvement in skin and soft tissue infections	71
Italian epidemiology of Gram negative bloodstream infections over 4-year period	69
Daptomycin-containing regimens for treatment of Gram-positive endocarditis	69
Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study	69
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia	68
Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy	68
Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction	68
Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19	68
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?	67
Totale	9.348

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	68.151
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	68.151

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	219	0	1	0	1	2	2	0	0	112	22	2	77
2022/2023	628	48	3	7	75	44	209	2	85	94	29	16	16
2023/2024	2.797	386	446	421	537	610	200	35	47	45	17	11	42
2024/2025	1.780	7	39	323	81	59	100	89	74	236	154	153	465
2025/2026	4.751	283	330	399	536	322	187	1.044	275	482	349	307	237
2026/2027	516	216	300	0	0	0	0	0	0	0	0	0	0
Totale													10.771